Skip to end of metadata
Go to start of metadata



Dial-in Number

  • One tap mobile
    +13126266799,,3231998494# US (Chicago)
    +13462487799,,3231998494# US (Houston)
  • Dial by your location
    +1 312 626 6799 US (Chicago)
    +1 346 248 7799 US (Houston)
    +1 669 900 6833 US (San Jose)
    +1 929 436 2866 US (New York)
    +1 253 215 8782 US
    +1 301 715 8592 US
    Meeting ID: 323 199 8494
    Find your local number:

Web session

HL7 Antitrust Policy

Professional Associations, such as HL7, which bring together competing entities are subject to strict scrutiny under applicable antitrust laws. HL7 recognizes that the antitrust laws were enacted to promote fairness in competition and, as such, supports laws against monopoly and restraints of trade and their enforcement. Each individual participating in HL7 meetings and conferences, regardless of venue, is responsible for knowing the contents of and adhering to the HL7 Antitrust Policy as stated in §05.01 of the Governance and Operations Manual (GOM).


Please include your organization in your Zoom name.

  • Click on your picture/name in Zoom
  • Click on rename
  • enter <name> - <organization>
Danielle BancroftBest Practice Software
Melva Peters Jenaker Consultingx
Jean Duteau Duteau Designx
John HatemIndependent Consultant
Scott Robertson (Chair)Kaiser Permanentex
Christof GessnerHL7 Germany
Corey SpearsMITREx
Dave HillMITRE
Frank McKinneyPOCPx
Isaac VetterEpic
Smile CDRx
Lawrence LoColumbia University HIT Student
Margaret WeikerNCPDPx
Matt SzczepankiewiczEpic
Peter SergentHL7 New Zealand
Reed D. GelzerTrustworthy EHR
Shelly SpiroPharmacy HIT Collaborativex
Stephen ChuADHAx
Tim McNeilSurescripts
Kim RobertsPharmacy HIT Collaborativex
Kent BulzaWell Healthx
Phung Matthews3Mx
Jack BrashierEpic
Emmanuel Obasuyi

Joel MontavonPQA
Robb YoungPharmID
Christopher Isong

Gary SchoettmerNetRx
Courtney BlandCVS / Aetna
Mark NeumuthAetna
Ed MillikanFDA
Sanket RavalCVS / Aetna

Agenda Items and Notes

Outstanding Action Item List

Meeting Notes from previous meeting

Project Review

Project Proposals

Project Scope Statements

External Meeting Review

Catalog Updates (John Hatem)

  • - reviewed existing ballot materials - next meeting is July 8th
    • Catalog project open to meeting - ask us to go to their meeting on Fridays at 12 noon Eastern
      • Best date at this point is Sept 2, or Sept 9, 2022, since Francois is out all of August and I am out all of July. 
    • FYI, the IG work will not be balloted in Sept, 2022 WGM - many open issues. 
  • John not available for update

Workflow Update (John Hatem) 

  • - Meeting cancelled this week

Healthcare Product Update (John Hatem)

  • - Addressing trackers for BDP and other resources. This work also included improving descriptions for several elements and reviewing the value sets. No Pharmacy impact at this time. 
  • - John not available for update

EHR conformant reconciled medication list (cRML) (Scott Robertson / John Hatem)

  • - have not been meeting
    • may be meeting with NCPDP on July 6th
    • Shelly has a Masters Student (until April 2023 for project) who will be doing thesis on Standardized Medication List - funding and how to move foward
      • cRML is part of this - hope to get it moving again
    • next call on 14 July
    • New leadership on WG14/WG10 Standardized Medication Profile Task Group call on  
      • James Tcheng, Center for Intelligent Healthcare (CIHC) - update on the current prototype project plan
        • Collaboration between Duke and University of Nebraska
        • HL7 – Reducing clinician burden work group
      • Emory Fry, CEO of Saperi Systems, will provide a brief on the current state of knowledge gaps, if any, on NCPDP domain Standards
      •  Draft Overview of Medication Reconciliation.pdf

NCPDP Updates (NCPDP Members)

All NCPDP Meeting information can be obtained at

WG18 Patient Consent TG:

MC Consumer and Provider RTPB Standards Monitoring Sub-Task Group

  • - didn't meeting this week
    • will meet as needed
    • CARIN IG - haven't moved forward with updates to the IG
      • Frank informally responding to questions
    • NCPDP group is monitoring legislative changes and impact on NCPDP standard and CARIN IG
  • - have not met in last month


PDex Formulary (Corey)

  • - no update
  • - 2 items will be sent to list
    • will need discussion/vote on next weeks call
    • will be coming for approval of a publication request following this and then updates to the IG
      • request approval after completing updates to the IG

Pharmacist Consult Note (Scott)

    • NCPDP TG decided to continue with the HL7/NCPDP guidance document and possibly tackle an IG at a later date.
    • NCPDP meetings are scheduled for June 16, June 30, and July 14 at 10:00 am US Central Time
    • NIB for approval - reviewed and updated
    • Motion - Scott and Margaret to approve NIB - 11-0-0 Carried
    • NIB submitted
    • working on content - working on additional use cases
  • - no update
  • - some additional edits have been made
    • need final content for September ballot

FHIR (Group)

Trackers - link to pharmacy unresolved Jira trackers (see trackers for details / resolutions)

  • FHIR-37622 - should belong to FHIR-I - move workgroup 

Any Other Business

Next meeting: